Pfizer gets EU approval for kids' cholesterol drug
Court Alerts
The European Union has approved a new chewable form of cholesterol blockbuster Lipitor for children 10 and up with high levels of bad cholesterol and triglycerides, a type of blood fat, Pfizer said Tuesday.
The approval includes children whose high blood fats are due to an inherited disease that causes extremely high cholesterol levels, familial hypercholesterolemia.
New York-based Pfizer Inc. won U.S. approval for Lipitor use in children 10 to 17 with that condition in 2002.
Lipitor is the world's top-selling drug, with 2009 sales of about $13 billion, but its U.S. patent expires at the end of November 2011. Pfizer, the world's biggest drugmaker, will quickly lose most Lipitor revenue once generic competition hits, so the company has been trying to boost sales where possible before then.
Pfizer said last fall that it plans to apply for a six-month extension of its patent in European countries, after doing studies of Lipitor in youngsters.
As in the United States, the European Union allows drug makers to seek an additional six months of patent protection for medications if they test them in children, who generally are excluded from the drug studies performed to win approval for a new medication.
Related listings
-
Appeals court orders new hearing for detainee
Court Alerts 07/06/2010A U.S. appeals court says an Algerian protesting his Guantanamo detention deserves a new lower court review. The review should determine whether he was part of al-Qaida.The three-judge panel reversed a decision that concluded Belkacem Bensayah's impr...
-
Former mortgage exec pleads not guilty in Va.
Court Alerts 07/02/2010The former head of a mortgage lending company accused of scheming to steal more than $500 million from the government's financial bailout fund has pleaded not guilty in the case.Lee Bentley Farkas entered the not guilty plea Friday in Alexandria, Va....
-
Trucker gets life term for attacks on 2 Pa. women
Court Alerts 06/30/2010A former trucker serving at least 75 years in prison for knife attacks on women in New Jersey and Massachusetts will spend the rest of his life in prison after pleading guilty to similar charges in Pennsylvania.Forty-five-year-old Adam Leroy Lane ple...
New York Commercial Litigation Law Firm - Woods Lonergan PLLC
Founded in 1993 by Managing Partner James F. Woods, Woods Lonergan PLLC has built a strong reputation as a resourceful and industrious firm that provides clients with clear, concise, and straightforward answers to their most challenging legal issues. Partner Lawrence R. Lonergan, who joined the firm in 2008, has been a friend and colleague to Mr. Woods for over 40 years and shares the same business philosophy. Woods Lonergan PLLC’s collective experience and expertise enables the firm to expeditiously and effectively analyze the increasing challenges clients face in an evolving business and legal world, in many instances, avoiding unnecessary time and expense to our clients. Our mission is simple: provide cutting-edge expertise and sound advice in select areas of the law for corporate and business clients. We thrive on providing each client with personalized attention, forceful representation, and a collaborative team effort that embraces collective knowledge.